Drugs at the wheel: 2024 figures confirm a major prevention challenge
Share
In 2024, law enforcement conducted about 1.2 million drug tests on French roads. According to ONISR, 11.1% of these tests were positive. Behind this figure lies a public safety issue, but also a direct challenge for companies, local authorities, transporters, and all sectors where vigilance is essential.
A figure that confirms the scale of the road risk
Drugs while driving remain a major road safety issue. Driving after consuming cannabis, cocaine, amphetamines, methamphetamines, opiates, or other psychoactive substances can impair reflexes, danger perception, coordination, alertness, and the ability to make quick decisions.
The figure of 11.1% positive tests does not mean that 11.1% of all French drivers use drugs. It concerns those actually tested, in contexts that may include targeted checks, offenses, accidents, or specific operations.
Approximate number of drug tests conducted on French roads in 2024.
Positivity rate recorded among people checked, all contexts combined.
Driving after drug use results in a 6-point deduction on the license.
Important: these figures should be interpreted with caution. They reflect a concerning reality on the roads but should not be generalized to all drivers without considering the context of the checks.
Why are drugs so dangerous when driving?
Drug use can profoundly alter driving behavior. Depending on the substance consumed, effects may include decreased alertness, deceptive euphoria, excessive risk-taking, drowsiness, poor distance judgment, or longer reaction times.
The danger increases even more when drugs are combined with alcohol, certain medications, or fatigue. In these situations, the effects can add up and make driving particularly dangerous.
Cannabis / THC
Possible effectsDecreased alertness, altered perception, longer reaction time.
Main riskDifficulty anticipating dangers and reacting quickly.
Cocaine
Possible effectsExcitement, excessive feeling of control, impulsiveness.
Main riskRisk-taking, excessive speed, aggressive driving.
Amphetamines / methamphetamines
Possible effectsArtificial stimulation, nervousness, masked fatigue.
Main riskLoss of control, overestimation of abilities, sudden exhaustion.
Opiates and diverted medications
Possible effectsDrowsiness, slowing down, decreased concentration.
Main riskSleepiness, delayed reaction, dangerous driving.
What penalties apply for driving after drug use?
In France, driving after drug use is a criminal offense. Penalties can be severe: point deduction, fines, license suspension or revocation, vehicle immobilization, or imprisonment in the most serious cases.
In cases combined with alcohol, bodily injury accidents, or repeat offenses, consequences can be aggravated. Beyond criminal penalties, human, professional, and insurance consequences can be significant.
Point deduction
ConsequenceDriving after drug use results in a 6-point deduction on the driving license.
Fines and prosecution
ConsequenceThe driver faces fines, criminal prosecution, and additional sanctions.
License suspension
ConsequenceThe license may be suspended or revoked depending on the severity of the facts and context.
Increased liability
ConsequenceIn case of an accident, legal and human consequences can be severe.
A direct challenge for companies and high-risk positions
The issue of drugs is not limited to the road. It also concerns the professional world, especially when employees hold positions where reduced vigilance can create danger for themselves, colleagues, users, or third parties.
Relevant sectors may include transport, logistics, construction, industry, private security, technical interventions, roadwork, or positions where errors can have serious consequences.
Inform
Implement clear communication on the risks related to drugs, alcohol, and psychoactive substances.
Train
Raise awareness among teams, managers, and safety officers about warning signs and internal obligations.
Supervise
Define a protocol compliant with the legal framework, internal regulations, and identified high-risk positions.
Screen
Use reliable tests, adapted to the context, with a clear, proportionate, and documented procedure.
Warning: in the workplace, testing must be regulated. It should not be improvised. It must be part of a coherent, proportionate prevention policy compliant with labor law.
Saliva or urine tests: what solutions for prevention?
Screening tests do not replace training, dialogue, or the legal framework. However, they can become useful tools when integrated into a responsible risk prevention approach.
Saliva tests
Saliva tests are suitable for situations requiring rapid and non-invasive screening. They are particularly relevant in road safety contexts, professional prevention, or field interventions.
Urine tests
Urine tests allow detection of several substance families depending on the references used. They can be useful in self-monitoring, prevention, or support processes depending on the applicable framework.
Company protocols
For employers and organizations exposed to risks, the challenge is to combine information, documentation, training, internal rules, and reliable screening tools.
Research related to the terms drug saliva test, drug saliva screening, drug urine test, workplace drug screening, driving under the influence of drugs, and road safety prevention shows a growing demand for reliable information, quick solutions, and clear protocols.
Plan Joana, school transport, and prevention of risky behaviors
The issue of drug use while driving has also become central in discussions about collective transport safety, especially following announcements related to the Plan Joana. This plan aims to strengthen road safety in school transport, with particular attention to risks related to addictions, alcohol, and drugs.
For transport actors, local authorities, and companies involved in professional driving, these developments highlight the importance of anticipation. Prevention should not be limited to reacting after an incident. It must be organized upstream: awareness, training, internal procedures, risk assessment, and choosing appropriate screening solutions.
How to implement a responsible prevention approach?
An effective prevention policy does not rely solely on purchasing tests. It must be designed as a complete, coherent, and documented system. The goal is not to stigmatize but to prevent accidents, protect people, and secure sensitive professional situations.
Identify high-risk positions
ObjectiveIdentify situations where impaired alertness can create danger.
Concrete applicationDriving, transport, machinery, safety, technical interventions, construction sites, handling.
Informing teams
GoalExplain risks, internal rules, and possible consequences.
Practical applicationPosting, safety booklet, prevention meeting, internal memo, manager awareness.
Legal framework
GoalEnsure a proportionate, clear, and compliant approach.
Practical applicationInternal regulations, written procedures, prior information, compliance with the applicable framework.
Choosing the right tools
GoalUse tests adapted to the context and substances sought.
Practical applicationSaliva tests, urine tests, multi-drug tests, support from a specialized supplier.
The role of AMA Prévention
AMA Prévention supports individuals, professionals, companies, local authorities, and field actors with testing and prevention solutions adapted to current challenges.
Our goal is not to dramatize but to enable everyone to act with reliable tools, clear information, and a responsible approach. Faced with the risks of drugs and driving, prevention must remain concrete, measurable, and operational.
The tests offered by AMA Prévention are selected to meet user needs: rapid control, professional use, workplace prevention, road safety, self-testing, or support for internal prevention policies.
Need a reliable testing solution for your teams or organization?
AMA Prévention supports companies, transporters, local authorities, health professionals, and organizations exposed to risks with testing solutions that are adapted, reliable, and integrated into a responsible prevention approach.
Frequently asked questions about drugs and driving
What is the positive drug test rate in 2024?
According to ONISR, about 1.2 million drug tests were conducted in France in 2024. The positivity rate was 11.1% across all contexts.
Does this figure mean that 11.1% of French drivers use drugs?
No. This figure concerns drivers tested, not all French drivers. Tests can be targeted, conducted during offenses, accidents, or control operations.
What are the penalties for driving after drug use?
Driving after drug use is a crime punishable by up to 3 years in prison, a €9,000 fine, and a 6-point license suspension. Penalties are increased if combined with alcohol or in the event of a serious accident.
Can companies implement prevention actions?
Yes. Companies can implement information, training, and prevention actions. However, the use of testing must be regulated, proportionate, compliant with labor law, and reserved for situations where safety justifies it.
Which test to choose: saliva or urine?
The choice depends on the context of use. The saliva test is often preferred for quick and non-invasive screening. The urine test may be suitable for broader detection depending on the targeted substances and the chosen reference.
Can a saliva test be used in a professional prevention approach?
Yes, provided its use is regulated, proportionate, and integrated into a clear prevention policy. In companies, testing must comply with the applicable legal framework, especially when people's safety is at stake.
Conclusion: prevention must come before control
The official 2024 figures confirm that drug use while driving remains a major road safety issue. The response cannot be limited to sanctions. It must also include serious prevention, clear messages, reliable tools, and protocols adapted to real-world conditions.
For both individuals and professionals, the priority remains the same: to prevent an individual risk-taking from becoming a human, legal, or professional tragedy.
Official sources
Data used: ONISR, 2024 report on offenses and road safety data; Service-public.fr, sanctions related to driving after drug use. Article written for information and prevention purposes, without replacing individualized legal advice.
Scientific validation of B-SAFE
The B-SAFE project, a drug detector pen for drinks, is validated and supported by Professor Jean-Claude Alvarez, toxicologist, professor of pharmacology-toxicology, and director of the toxicology laboratory at CHU Raymond-Poincaré/AP-HP in Garches.
A leading authority in toxicology, he is associated with the reference work conducted in France on psychoactive substances and chemical submission, in a national ecosystem also supported in public debate by voices such as Sandrine Josso and Caroline Darian.
This validation strengthens B-SAFE's technological positioning and the accuracy of its detection for drug prevention in drinks. Discover the B-SAFE product sheet.
